Tvardi Therapeutics, Inc. (LSE:0HTC) IPO

Tvardi Therapeutics, Inc.

IPO

Went public as Cara Therapeutics, Inc. Priced at US$11.00 a share on Jan 30, 2014.

Price
US$11.00 a share
Shares offered
5,000,000 shares of common stock
Offering size
US$55 million
Underwriters' option
Up to 750,000 more shares
Underwriters
Stifel, Piper Jaffray, Canaccord Genuity, Needham & Company, Janney Montgomery Scott · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceOct 4, 2013
Filed publiclyNov 8, 2013
Amended twiceNewest Jan 17, 2014
Shares registered with an exchangeJan 27, 2014
Declared effective by the SECJan 30, 2014
Final prospectus, with the priceFeb 3, 2014

From the cover of the final prospectus (424B4) filed Feb 3, 2014